Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Pharmala Biotech Hldgs Stock News

MDXXFOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Pharmala Biotech Hldgs (MDXXF) Forecast

News

Earnings Pharmala Biotech Hldgs (MDXXF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Pharmala Biotech Hldgs Stock News | OTC:MDXXF | Benzinga

Get the latest news on Pharmala Biotech Hldgs stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Pharmala Biotech Hldgs performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, October 21, 2024

PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial
Juan Spínelli

Tuesday, October 08, 2024

PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial
Juan Spínelli

Wednesday, October 02, 2024

PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial
Juan Spínelli

Wednesday, September 11, 2024

PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
Juan Spínelli

Wednesday, May 29, 2024

Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale
Patricio Liddle

Wednesday, April 17, 2024

Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein

Saturday, March 30, 2024

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Lara Goldstein

Friday, March 29, 2024

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Lara Goldstein

Wednesday, March 27, 2024

PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development
Lara Goldstein

Tuesday, March 26, 2024

Two Top Biotechs Forge MDMA Supply Deals For An Expanding Research Field
Lara Goldstein

Monday, March 11, 2024

Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale
Lara Goldstein

Wednesday, February 28, 2024

Red Light Holland Exports Psilocybin For Research, Microdosing Capsules And More News From This Canadian Company
Lara Goldstein

Thursday, February 15, 2024

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein

Friday, January 26, 2024

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved